for the treatment of overactive bladder (OAB).This is the first time that CTAF has addressed this topic.

[7] Among men with both DO and BOO that did not improve on alpha-blocker monotherapy, 73% did show symptomatic improvement after 3 months of tolterodine treatment. Urge urinary incontinence ...

Patients with chronic overactive bladder (OAB) are usually treated long-term with antimuscarinic agents. However, adherence to treatment is poor—rates as low as 20% at 1 year have been reported ...

An overactive bladder (OAB) causes a sudden and frequent urge to urinate, often leading to involuntary leakage. While conventional treatments such as medications, bladder training, and lifestyle ...

U of U Health is the Mountain West’s foremost academic medical center. When you come to us for incontinence treatment, you can expect: Effective incontinence treatment starts with pinpointing the ...

Botox has been shown to be an effective treatment option for bladder problems. In studies, people who received Botox injections for overactive bladder (OAB) symptoms saw improvements in certain ...

This approach is expected to offer patients a less invasive, more comfortable treatment option compared to traditional injections, potentially transforming the standard of care for OAB.

Gemtesa (vibegron) is a prescription drug used to treat symptoms of overactive bladder (OAB). Gemtesa can cause side effects that range from mild to serious. Examples include headache, nausea, and ...